The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey

Altuntaş, Nilgün; Yenicesu, İdil; Himmetoğlu, Özdemir; Kulalı, Ferit; Kazancı, Ebru; Ünal, Sezin; Aktaş, Selma; Hırfanoğlu, İbrahim Murat; Önal, Esra; Türkyılmaz, Canan; Ergenekon, Ebru; Koç, Esin; Atalay, Yıldız

doi:10.1016/j.transci.2013.04.021

Cited by 21 publications

(20 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, large-scale studies on pregnant women need to be done in order to collect sufficient evidence to formulate guidelines and to define indications for alloantibody screening and identification. 11 Alvey JP in their study on Rh Incompatibility, which was an investigation in 200 cases, found that spectrophotometric analysis of a single specimen of liquor amnii, preferably taken at 32 weeks, affords a means of accurately determining the extent of the hemolytic process, especially when regard is given to both the type of curve produced and to a quantitative assessment of bilirubin in the liquor. By this method, it is possible to segregate all cases of Rh isoimmunization into three groups, designated A, B, and C. It is suggested that induction of labor is unnecessary in Group A (26.5 per cent of cases), that induction of labor at 38 weeks suffices in Group B (41 per cent of cases), and that, between 34 and 36 weeks, it is indicated in Group C (32.5 per cent of cases).5.…”

Section: Discussionmentioning

confidence: 99%

Maternal and perinatal outcome in Rh negative mothers

Tripathi¹,

Singh²

2018

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

Background: The objective of this study is to find out the incidence and foetomaternal outcome of Rh negative women during pregnancy.Methods: In the study group, the labor was monitored carefully and the mode of delivery and the outcome of labor was studied in detail. Baby was thoroughly examined for any obvious congenital anomaly, weight, sex and condition was also noted particularly for hydrops. If neonate was Rh positive, then the mother was given postpartum immunoprophylaxis within 24 hours of delivery. The new born were followed for 3 days and were watched for the development of Jaundice. Mothers were advised to attend postnatal clinic for check-up after 6 weeks of delivery.Results: Blood group distribution of newborn: 37 were Rh positive and 18 were Rh negative. Raised Rh antibody titre was not found in any of the 55 cases. Maximum cases 47 delivered at 38-40 weeks, 2 cases delivered after 40 weeks and 6 patients delivered between 30-38 weeks. Maximum cases 37 delivered normally, 12 required cesarean section and 2 had forceps delivery. The babies who developed NNHB were managed either by sunrays exposure only or by phototherapy. The babies who had anemia immediately after birth were carefully monitored and considered for exchange transfusion.Conclusions: Tremendous advances in the medical services and technology during the last few decades have revolutionized the treatment of Rh disease. Various studies have been conducted and several are going on the in this field to achieve zero incidence of this disease.

show abstract

Section: Discussionmentioning

confidence: 99%

Maternal and perinatal outcome in Rh negative mothers

Tripathi¹,

Singh²

2018

Int J Reprod Contracept Obstet Gynecol

View full text Add to dashboard Cite

show abstract

“…Northwestern European Caucasian women have the highest prevalence (15%), followed by Africans (8%) and Asians (ranging from 0.3% in women in Thailand to 5% in women in India and 7.5% in Saudi Arabia) . In addition to the varying frequencies of RhD negativity in pregnant women from various genetic backgrounds a low prevalence of RBC antibodies (e.g., c, D, Kell) and HDFN was observed . It is unknown whether lower occurrence of HDFN is directly linked to the low prevalence of RhD negativity in non‐Western countries.…”

mentioning

confidence: 99%

“…1,8,9 In addition to the varying frequencies of RhD negativity in pregnant women from various genetic backgrounds a low prevalence of RBC antibodies (e.g., c, D, Kell) and HDFN was observed. [4][5][6][7][8][9] It is unknown whether lower occurrence of HDFN is directly linked to the low prevalence of RhD negativity in non-Western countries. Women in those countries may also express less aggressive antibodies due to the presence of RhD antigen variants or genetic or environmental circumstances.…”

mentioning

confidence: 99%

RhD negativity among pregnant women in multiethnic Suriname

et al. 2015

View full text Add to dashboard Cite

show abstract

“…India [11] 2180 51 (2.4) India [10] 305 27 (8.9) Czech Republic [8] 6815 181 (2.6) Turkey [12] 743 65 (8.7) Nigeria [13] 280 12 (4.3) Uganda [14] 72 4 (5.6) India [15] 270 35 (13) Thailand [16] 72 7 (10) Nigeria [17] 67 6 (9) Zimbabwe [18] 629 25 (4) Zimbabwe [14] 85 4 (4.7) Mexico [20] 4857 631 (13) Cameroon [21] 225 9 (4) Iraq [22] 142 7 (4.9)…”

Section: Countrymentioning

confidence: 99%